Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2006, Vol. 108, No. 10, pp. 3305-3312.
Prepublished online as a Blood First Edition Paper on July 20, 2006; DOI 10.1182/blood-2006-04-014829.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-014829v1
108/10/3305    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, T.
Right arrow Articles by Tsunetsugu-Yokota, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, T.
Right arrow Articles by Tsunetsugu-Yokota, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 6, 2006
Accepted June 29, 2006

Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages

Takuya Yamamoto, Hiroyuki Miyoshi, Norio Yamamoto, Naoki Yamamoto, Jun-ichiro Inoue, and Yasuko Tsunetsugu-Yokota*

National Institute of Infectious Diseases; The University of Tokyo, Tokyo, Japan
Subteam for Manipulation of Cell Fate, BioResource Center, RIKEN Tsukuba Institute, Tsukuba, Japan
Department of Molecular Virology, Bio-Response, Tokyo Medical and Dental University, Tokyo, Japan
Tokyo Medical and Dental University; National Institute of Infectious Diseases, Tokyo, Japan
Department of Cancer Biology, The Institute of Medical Science, The University of Tokyo, Japan
Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan

* Corresponding author; email: yyokota{at}nih.go.jp.

Although successful attempts to inhibit HIV-1 replication in T-cells using RNAi have been reported, the effect of HIV-specific RNAi on macrophages is not well known. Macrophages are key targets for anti-HIV-1 therapy, because they are able to survive long after the initial infection with HIV, and can spread the virus to T-cells. In this study, we identified a putative RNAi target of HIV, consisting of the portion of the nef gene overlapping the U3 region (Nef366), and generated a lentivirus-based short hairpin RNA (shRNA) expression vector (Lenti shNef366). We showed here that Lenti shNef366 inhibits 1) HIV-1 replication in a monocytic cell line and in primary monocyte-derived macrophages (MDMs), 2) reactivation of latent HIV-1 infection, and 3) the production of secondary HIV-1 from MDMs harboring a genomic copy of Nef366. Moreover, we found that the upregulated production of macrophage inflammatory protein-1{beta} (MIP-1{beta}), but not MIP-1{alpha}, in MDMs by Nef expression was considerably suppressed by Lenti shNef366, which suggests that HIV-1 dissemination to T-cells through its interaction with HIV-1 infected MDMs can also be controlled by Lenti shNef366. Thus, lentivirus-mediated shRNA expression targeting the U3-overlapping region of HIV nef represents a feasible approach to genetic vaccine therapy for HIV-1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Watarai, E. Sekine, S. Inoue, R. Nakagawa, T. Kaisho, and M. Taniguchi
PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon
PNAS, February 26, 2008; 105(8): 2993 - 2998.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020